Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

How This Policy Change Impacted Genetic Testing Access

J Oncol Pract; ePub 2016 Oct 23; Whitworth, et al

Mandating the use of a genetic counselor lowered access to appropriate testing but did not seem to decrease inappropriate testing in a study involving a health plan that instituted such a policy.

Investigators compared test cancellation rates, mutation-positive rates, and turnaround times for comprehensive BRCA1/2 testing both before and after the policy change. They also looked at a control group that was not subject to the change. Among the results:

  • Cancellation rate increased from 13% before the policy change to 42% afterwards.
  • Cancellation rate increase was also seen in those who met NCCN criteria for testing; the rate went from 10% to 38%.
  • Cancellation rates rose across all ethnicities, but increased more so in blacks and Hispanics (to ~50% in both groups).
  • The rate increased to 34% in whites.
  • Cancellation rates decreased or stayed the same for all control participants.

Citation:

Whitworth P, Beitsch P, Arnell C, et al. Impact of payer constraints on access to genetic testing. [Published online ahead of print October 23, 2016]. J Oncol Pract. doi:10.1200/JOP.2016.013581.